跳至主要内容
临床试验/ISRCTN83567338
ISRCTN83567338已完成不适用

A randomised, double-blind, placebo controlled trial to compare the early administration of intravenous haloperidol versus placebo in the prevention and treatment of delirium in critically ill ventilated patients

West Hertfordshire Hospitals NHS Trust (UK)0 个研究点目标入组 142 人开始时间: 2011年1月21日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
142

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients requiring mechanical ventilation within 72 hours of admission
  • 2. Male and female, aged 18 - 99 years

排除标准

  • 1. Allergy to haloperidol
  • 2. Chronic antipsychotic use
  • 3. QTc greater than 500 msecs
  • 4. History of torsades de pointes
  • 5. Family history of dystonic reactions
  • 6. Moribund and not expected to survive
  • 7. Uncomplicated elective surgery
  • 8. Expected to stay less than 48 hours
  • 9. Moderate/severe dementia
  • 10. Pregnancy
  • 11. Parkinsons disease
  • 12. Structural brain damage
  • 13. History of neuroleptic malignant syndrome
  • 14. Patients who do not understand English

研究者

发起方
West Hertfordshire Hospitals NHS Trust (UK)

相似试验